BIOGEN - TO CONTINUE TO URGE CMS TO ALIGN MEDICARE COVERAGE FOR CLASS OF AMYLOID-DIRECTED THERAPIES WITH POPULATIONS STUDIED IN RESPECTIVE CLINICAL TRIALS, FOR APPROPRIATE USE
Biogen - To Continue To Urge Cms To Align Medicare Coverage For Class Of Amyloid-Directed Therapies With Populations Studied In Respective Clinical Trials, For Appropriate Use
![Reuters logo](/images/reuters.jpg)